Thermo Fisher Scientific (TMO) Tops Q3 EPS by 6c; Lowers Outlook
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $464.61 +0.63%
EPS Growth %: +6.7%
Financial Fact:
Product revenues: 3.87B
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +6.7%
Financial Fact:
Product revenues: 3.87B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.69, $0.06 better than the analyst estimate of $5.63. Revenue for the quarter came in at $10.57 billion versus the consensus estimate of $10.62 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2023 EPS of $21.50, versus the consensus of $22.31. Thermo Fisher Scientific sees FY2023 revenue of $42.7 billion, versus the consensus of $43.53 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
- SpaceX receives Baa1 rating from Moody's with stable outlook
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
